2025 annual financial data
Cadrenal Therapeutics 2025 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -13,461,177 USD and net income was -13,237,362 USD.
Operating cash flow was -12,601,666 USD.
Get free Cadrenal Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,461,177 USD
- Net income
- -13,237,362 USD
- Operating cash flow
- -12,601,666 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Cadrenal Therapeutics financial years